| 2.4 |
7.3 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 2.0 |
8.0 |
GO:0003360 |
brainstem development(GO:0003360) |
| 2.0 |
9.8 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 1.9 |
5.8 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 1.8 |
10.7 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 1.8 |
1.8 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 1.7 |
7.0 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 1.5 |
4.5 |
GO:0060489 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.5 |
5.8 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 1.4 |
5.8 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 1.4 |
1.4 |
GO:0003134 |
BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) cell-cell signaling involved in cell fate commitment(GO:0045168) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 1.4 |
1.4 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 1.4 |
5.6 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 1.4 |
2.8 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 1.4 |
9.6 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 1.4 |
4.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 1.3 |
4.0 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 1.3 |
3.9 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 1.3 |
3.9 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.3 |
3.8 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.2 |
6.2 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 1.2 |
11.1 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.2 |
4.9 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 1.2 |
6.0 |
GO:0035878 |
nail development(GO:0035878) |
| 1.2 |
1.2 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 1.2 |
4.6 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 1.2 |
2.3 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 1.2 |
1.2 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.1 |
5.7 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 1.1 |
6.9 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 1.1 |
4.5 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 1.1 |
3.4 |
GO:1905223 |
epicardium morphogenesis(GO:1905223) |
| 1.1 |
10.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 1.1 |
2.2 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.1 |
3.3 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 1.1 |
5.5 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 1.1 |
3.3 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.1 |
8.6 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 1.1 |
3.2 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.1 |
3.2 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.1 |
3.2 |
GO:0021998 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
| 1.1 |
1.1 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 1.1 |
3.2 |
GO:0061075 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 1.0 |
3.1 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.0 |
1.0 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 1.0 |
6.1 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 1.0 |
1.0 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 1.0 |
4.0 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 1.0 |
1.0 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 1.0 |
1.0 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.9 |
2.8 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.9 |
2.8 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.9 |
2.8 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 0.9 |
2.8 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.9 |
5.5 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.9 |
4.5 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.9 |
0.9 |
GO:0060423 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.9 |
1.8 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.9 |
2.7 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.9 |
3.6 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.9 |
2.7 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.9 |
3.5 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.9 |
2.6 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 0.8 |
3.4 |
GO:1904393 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 0.8 |
2.5 |
GO:0045004 |
DNA replication proofreading(GO:0045004) |
| 0.8 |
0.8 |
GO:0033278 |
cell proliferation in midbrain(GO:0033278) |
| 0.8 |
2.5 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.8 |
3.3 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.8 |
2.5 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.8 |
1.6 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.8 |
2.4 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.8 |
7.9 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
| 0.8 |
0.8 |
GO:2000137 |
negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
| 0.8 |
2.3 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.8 |
3.0 |
GO:0061312 |
BMP signaling pathway involved in heart development(GO:0061312) |
| 0.8 |
2.3 |
GO:0045819 |
plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 0.8 |
2.3 |
GO:0016132 |
brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 0.7 |
2.2 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.7 |
5.9 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.7 |
0.7 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.7 |
3.7 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.7 |
2.8 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.7 |
11.9 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.7 |
2.1 |
GO:0038044 |
transforming growth factor-beta secretion(GO:0038044) |
| 0.7 |
4.2 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.7 |
6.2 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.7 |
2.1 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 0.7 |
2.7 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.7 |
1.4 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.7 |
2.7 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.7 |
0.7 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.7 |
6.7 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.7 |
2.6 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.7 |
2.0 |
GO:0072708 |
response to sorbitol(GO:0072708) |
| 0.7 |
0.7 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.6 |
0.6 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.6 |
2.6 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.6 |
1.9 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.6 |
1.3 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.6 |
1.9 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.6 |
3.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.6 |
4.4 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.6 |
1.9 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.6 |
0.6 |
GO:0031944 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
| 0.6 |
1.9 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.6 |
2.5 |
GO:0072103 |
renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.6 |
2.4 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.6 |
2.4 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.6 |
1.8 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.6 |
2.4 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.6 |
0.6 |
GO:2000054 |
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.6 |
1.2 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.6 |
0.6 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.6 |
4.2 |
GO:0098909 |
regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.6 |
0.6 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.6 |
1.8 |
GO:0021884 |
forebrain neuron development(GO:0021884) |
| 0.6 |
2.3 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.6 |
2.3 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.6 |
5.8 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.6 |
5.3 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.6 |
0.6 |
GO:0060298 |
positive regulation of sarcomere organization(GO:0060298) |
| 0.6 |
1.2 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 0.6 |
3.4 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.6 |
1.7 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.6 |
0.6 |
GO:2000850 |
negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.6 |
1.7 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.6 |
0.6 |
GO:0061046 |
regulation of branching involved in lung morphogenesis(GO:0061046) |
| 0.6 |
2.8 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.6 |
3.4 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.6 |
2.3 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.6 |
1.1 |
GO:0060849 |
regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.6 |
0.6 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.6 |
0.6 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.6 |
6.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.6 |
2.8 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.5 |
0.5 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.5 |
1.1 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.5 |
1.1 |
GO:0021861 |
forebrain radial glial cell differentiation(GO:0021861) |
| 0.5 |
3.8 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.5 |
4.8 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.5 |
1.6 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.5 |
0.5 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.5 |
1.6 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.5 |
3.2 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.5 |
1.6 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.5 |
3.2 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.5 |
5.7 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.5 |
3.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.5 |
0.5 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.5 |
1.6 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.5 |
1.5 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.5 |
0.5 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.5 |
2.6 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.5 |
2.0 |
GO:0061643 |
chemorepulsion of axon(GO:0061643) |
| 0.5 |
1.5 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.5 |
0.5 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.5 |
2.0 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.5 |
0.5 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.5 |
1.0 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.5 |
2.0 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.5 |
0.5 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.5 |
4.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.5 |
2.5 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.5 |
1.5 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.5 |
2.4 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.5 |
1.0 |
GO:0022028 |
tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.5 |
1.5 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.5 |
1.0 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.5 |
1.4 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.5 |
4.3 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.5 |
3.4 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.5 |
1.4 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) |
| 0.5 |
1.4 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.5 |
1.4 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.5 |
0.5 |
GO:0001743 |
optic placode formation(GO:0001743) |
| 0.5 |
1.9 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.5 |
2.8 |
GO:0086045 |
membrane depolarization during AV node cell action potential(GO:0086045) |
| 0.5 |
3.3 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.5 |
1.4 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.5 |
0.5 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.5 |
1.4 |
GO:0090004 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.5 |
0.5 |
GO:0002725 |
negative regulation of T cell cytokine production(GO:0002725) |
| 0.5 |
2.3 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.5 |
1.4 |
GO:0070650 |
actin filament bundle distribution(GO:0070650) |
| 0.5 |
0.9 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.5 |
1.4 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.5 |
0.5 |
GO:0060412 |
ventricular septum morphogenesis(GO:0060412) |
| 0.5 |
5.0 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.4 |
0.4 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.4 |
0.4 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.4 |
2.2 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.4 |
1.3 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.4 |
1.3 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.4 |
1.8 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.4 |
2.2 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.4 |
6.2 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.4 |
1.3 |
GO:1904719 |
excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.4 |
1.3 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.4 |
5.6 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.4 |
1.3 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.4 |
2.2 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.4 |
1.3 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.4 |
2.1 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.4 |
1.3 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.4 |
0.9 |
GO:0000448 |
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.4 |
1.3 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.4 |
2.1 |
GO:0002072 |
optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 0.4 |
0.4 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.4 |
0.4 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.4 |
1.3 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.4 |
0.4 |
GO:0060167 |
regulation of adenosine receptor signaling pathway(GO:0060167) |
| 0.4 |
1.7 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.4 |
1.3 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.4 |
1.3 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.4 |
0.8 |
GO:0060221 |
retinal rod cell differentiation(GO:0060221) |
| 0.4 |
1.7 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.4 |
0.4 |
GO:1900141 |
regulation of oligodendrocyte apoptotic process(GO:1900141) negative regulation of oligodendrocyte apoptotic process(GO:1900142) |
| 0.4 |
1.7 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.4 |
1.7 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.4 |
0.8 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.4 |
6.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.4 |
1.6 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.4 |
5.7 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.4 |
1.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 |
1.2 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.4 |
1.2 |
GO:0051135 |
positive regulation of NK T cell activation(GO:0051135) |
| 0.4 |
1.2 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.4 |
2.8 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.4 |
0.4 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.4 |
2.0 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.4 |
0.8 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.4 |
0.4 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.4 |
2.0 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.4 |
1.2 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.4 |
2.0 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.4 |
1.2 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.4 |
0.4 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.4 |
1.2 |
GO:1904975 |
response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.4 |
4.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.4 |
1.2 |
GO:1901355 |
response to rapamycin(GO:1901355) |
| 0.4 |
0.4 |
GO:0070988 |
demethylation(GO:0070988) |
| 0.4 |
1.5 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.4 |
0.8 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.4 |
1.5 |
GO:0035937 |
estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.4 |
0.8 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.4 |
1.5 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.4 |
2.3 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.4 |
0.4 |
GO:0044828 |
negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
| 0.4 |
0.8 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.4 |
6.0 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.4 |
0.4 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.4 |
0.8 |
GO:2000373 |
regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.4 |
0.4 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.4 |
0.7 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.4 |
1.5 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.4 |
1.1 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.4 |
0.7 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.4 |
0.7 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.4 |
1.5 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.4 |
1.5 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.4 |
2.2 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.4 |
2.2 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.4 |
1.5 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.4 |
1.1 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.4 |
3.6 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.4 |
0.7 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.4 |
2.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.4 |
1.4 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.4 |
0.4 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.4 |
1.8 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.4 |
1.8 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.4 |
3.9 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.3 |
1.0 |
GO:0001767 |
establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
| 0.3 |
0.7 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.3 |
1.0 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.3 |
0.7 |
GO:0002551 |
mast cell chemotaxis(GO:0002551) |
| 0.3 |
1.4 |
GO:0002265 |
astrocyte activation involved in immune response(GO:0002265) |
| 0.3 |
3.8 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.3 |
3.5 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.3 |
1.0 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.3 |
2.4 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.3 |
1.4 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.3 |
1.0 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.3 |
1.4 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.3 |
1.0 |
GO:1904207 |
chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.3 |
0.3 |
GO:0015822 |
ornithine transport(GO:0015822) |
| 0.3 |
1.0 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.3 |
3.7 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.3 |
1.0 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.3 |
0.7 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.3 |
0.7 |
GO:2000737 |
negative regulation of stem cell differentiation(GO:2000737) |
| 0.3 |
0.3 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.3 |
3.0 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.3 |
2.7 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.3 |
1.3 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.3 |
3.6 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.3 |
1.3 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.3 |
2.6 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.3 |
0.7 |
GO:0014857 |
regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.3 |
5.6 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.3 |
1.0 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.3 |
2.0 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.3 |
3.6 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.3 |
1.9 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.3 |
0.3 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.3 |
1.0 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.3 |
1.0 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 |
1.0 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.3 |
1.6 |
GO:0043153 |
photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.3 |
1.0 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.3 |
2.2 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.3 |
1.0 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.3 |
1.0 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 |
2.8 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.3 |
0.6 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
0.9 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 0.3 |
0.6 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.3 |
0.9 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.3 |
1.9 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.3 |
5.6 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.3 |
0.9 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.3 |
1.2 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.3 |
2.5 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.3 |
1.5 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.3 |
0.3 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.3 |
1.5 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.3 |
0.6 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.3 |
0.3 |
GO:0048340 |
paraxial mesoderm morphogenesis(GO:0048340) |
| 0.3 |
0.9 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.3 |
0.3 |
GO:0061515 |
myeloid cell development(GO:0061515) |
| 0.3 |
0.9 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.3 |
0.3 |
GO:0060028 |
convergent extension involved in axis elongation(GO:0060028) |
| 0.3 |
0.9 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.3 |
1.2 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.3 |
1.2 |
GO:0032899 |
regulation of neurotrophin production(GO:0032899) |
| 0.3 |
1.2 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.3 |
0.6 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.3 |
0.3 |
GO:0031657 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 0.3 |
0.6 |
GO:0070343 |
white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.3 |
2.4 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.3 |
1.8 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.3 |
0.3 |
GO:0099548 |
trans-synaptic signaling by soluble gas(GO:0099543) trans-synaptic signaling by nitric oxide(GO:0099548) |
| 0.3 |
0.9 |
GO:0072382 |
minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 0.3 |
0.9 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.3 |
0.9 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.3 |
1.2 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.3 |
0.6 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.3 |
2.9 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.3 |
1.8 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.3 |
1.7 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.3 |
0.9 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.3 |
4.3 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.3 |
1.2 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.3 |
1.7 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.3 |
0.9 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.3 |
1.4 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.3 |
1.7 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.3 |
3.1 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.3 |
0.3 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) |
| 0.3 |
0.8 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 |
0.3 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.3 |
0.3 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.3 |
0.3 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.3 |
0.8 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.3 |
0.3 |
GO:1903294 |
regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 0.3 |
0.8 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.3 |
0.5 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.3 |
1.6 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.3 |
0.8 |
GO:0019062 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.3 |
0.5 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.3 |
0.5 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 |
2.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 |
2.4 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.3 |
0.3 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.3 |
0.8 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.3 |
0.5 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.3 |
0.8 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.3 |
0.5 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.3 |
0.8 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.3 |
0.8 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.3 |
0.5 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.3 |
1.1 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.3 |
0.3 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.3 |
0.5 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.3 |
0.8 |
GO:0060430 |
lung saccule development(GO:0060430) |
| 0.3 |
0.8 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.3 |
0.8 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.3 |
0.3 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 |
0.3 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.3 |
0.8 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.3 |
0.8 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.3 |
0.8 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.3 |
0.8 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.3 |
1.0 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.3 |
0.5 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.3 |
0.8 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.3 |
0.3 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.3 |
0.3 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.3 |
1.0 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.3 |
1.0 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.3 |
0.3 |
GO:1904426 |
positive regulation of GTP binding(GO:1904426) |
| 0.3 |
0.8 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.3 |
0.5 |
GO:0035547 |
interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
| 0.3 |
0.8 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.3 |
1.3 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.3 |
1.5 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.2 |
3.2 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.2 |
1.2 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.2 |
1.7 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 |
3.4 |
GO:0046855 |
inositol phosphate dephosphorylation(GO:0046855) |
| 0.2 |
1.0 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
1.2 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.2 |
2.4 |
GO:0051571 |
positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.2 |
0.7 |
GO:0098928 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.2 |
0.7 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.2 |
0.5 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.2 |
0.2 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.2 |
0.2 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.2 |
0.7 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.2 |
1.2 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.2 |
0.7 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.2 |
1.2 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.2 |
2.4 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.2 |
1.7 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
2.2 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.2 |
0.5 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.2 |
1.4 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.2 |
0.2 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.2 |
1.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
1.4 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.2 |
0.2 |
GO:0042748 |
circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
| 0.2 |
1.2 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 |
1.9 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.2 |
1.4 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.2 |
1.4 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.2 |
1.7 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 |
0.5 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.2 |
1.2 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.2 |
0.9 |
GO:0061339 |
establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.2 |
1.2 |
GO:0009448 |
gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 |
0.2 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.2 |
0.7 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.2 |
0.9 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 0.2 |
0.9 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 |
0.7 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.2 |
0.9 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.2 |
0.5 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.2 |
1.8 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 |
0.9 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.2 |
1.6 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.2 |
2.3 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 |
0.9 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.2 |
1.1 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.2 |
1.4 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
0.5 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.2 |
0.2 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.2 |
0.4 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 |
0.2 |
GO:0050942 |
positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.2 |
1.1 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.2 |
0.4 |
GO:1900133 |
renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 0.2 |
0.9 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.2 |
2.2 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 |
2.9 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 |
0.7 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.2 |
2.4 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.2 |
0.4 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.2 |
1.1 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 |
0.4 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.2 |
0.9 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.2 |
0.4 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 |
0.9 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 |
0.2 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 |
0.7 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 |
0.6 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.2 |
0.4 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.2 |
0.6 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.2 |
0.6 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.2 |
0.6 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 |
0.9 |
GO:0060192 |
negative regulation of lipase activity(GO:0060192) |
| 0.2 |
0.4 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.2 |
0.6 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.2 |
1.3 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.2 |
1.3 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.2 |
1.5 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.2 |
0.4 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 |
0.2 |
GO:0086067 |
AV node cell to bundle of His cell communication(GO:0086067) |
| 0.2 |
0.6 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.2 |
0.8 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 |
0.4 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.2 |
1.1 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.2 |
2.7 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 |
0.6 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 |
0.4 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.2 |
0.4 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 |
0.4 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.2 |
0.6 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 |
0.8 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) |
| 0.2 |
1.2 |
GO:0031034 |
myosin filament assembly(GO:0031034) |
| 0.2 |
0.2 |
GO:1903463 |
regulation of mitotic cell cycle DNA replication(GO:1903463) |
| 0.2 |
1.4 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.2 |
1.0 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.2 |
0.4 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
0.8 |
GO:1904528 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.2 |
0.2 |
GO:0090190 |
positive regulation of mesonephros development(GO:0061213) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.2 |
0.8 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.2 |
0.4 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 |
2.4 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 |
1.0 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.2 |
0.8 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 |
0.6 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.2 |
1.0 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.2 |
0.2 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.2 |
0.4 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.2 |
0.6 |
GO:0042640 |
anagen(GO:0042640) |
| 0.2 |
3.6 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.2 |
0.8 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
0.8 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 |
0.4 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.2 |
0.4 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 |
1.2 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 |
1.2 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.2 |
1.2 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.2 |
0.2 |
GO:0003223 |
ventricular compact myocardium morphogenesis(GO:0003223) |
| 0.2 |
2.5 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 |
1.0 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 |
0.6 |
GO:0051105 |
regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.2 |
0.2 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.2 |
0.6 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.2 |
0.2 |
GO:0003174 |
mitral valve development(GO:0003174) mitral valve morphogenesis(GO:0003183) |
| 0.2 |
6.8 |
GO:1902808 |
positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.2 |
0.4 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.2 |
0.8 |
GO:0030540 |
female genitalia development(GO:0030540) |
| 0.2 |
1.0 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.2 |
2.1 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.2 |
0.6 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.2 |
2.3 |
GO:0060055 |
angiogenesis involved in wound healing(GO:0060055) |
| 0.2 |
0.4 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.2 |
1.0 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.2 |
0.8 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.2 |
0.4 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.2 |
1.0 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.2 |
0.4 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.2 |
3.2 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.2 |
0.2 |
GO:1905063 |
regulation of vascular smooth muscle cell differentiation(GO:1905063) |
| 0.2 |
0.6 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.2 |
0.4 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.2 |
0.9 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.2 |
0.8 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 |
1.1 |
GO:0030574 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.2 |
0.7 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.2 |
0.9 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.2 |
0.6 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.2 |
0.4 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.2 |
0.2 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.2 |
4.3 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.2 |
0.9 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.2 |
0.4 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.2 |
0.2 |
GO:1904170 |
regulation of bleb assembly(GO:1904170) |
| 0.2 |
0.7 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.2 |
0.2 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.2 |
2.2 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
0.7 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.2 |
0.4 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.2 |
0.4 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.2 |
0.4 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.2 |
0.4 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.2 |
0.9 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.2 |
0.4 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.2 |
1.4 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.2 |
0.9 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.2 |
0.5 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.2 |
0.2 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.2 |
0.5 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 |
0.2 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 |
0.5 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.2 |
0.5 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 |
1.4 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.2 |
1.2 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.2 |
0.2 |
GO:2000510 |
positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.2 |
0.5 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 |
5.0 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.2 |
0.7 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.2 |
4.3 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.2 |
0.3 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.2 |
1.9 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.2 |
1.7 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.2 |
5.6 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.2 |
3.7 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.2 |
0.7 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.2 |
0.8 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 |
2.5 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.2 |
1.7 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 |
1.5 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.2 |
1.0 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 |
0.8 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.2 |
3.7 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 |
1.8 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.2 |
0.3 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.2 |
0.3 |
GO:0040010 |
regulation of growth rate(GO:0040009) positive regulation of growth rate(GO:0040010) |
| 0.2 |
1.5 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.2 |
0.2 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.2 |
0.7 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 |
0.8 |
GO:0071731 |
response to nitric oxide(GO:0071731) cellular response to nitric oxide(GO:0071732) |
| 0.2 |
0.8 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.2 |
0.2 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.2 |
0.3 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.2 |
0.7 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.2 |
3.5 |
GO:1902751 |
positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.2 |
1.0 |
GO:1903077 |
negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.2 |
1.3 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
0.7 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.2 |
1.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.2 |
0.2 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.2 |
0.5 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.2 |
0.5 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.2 |
2.4 |
GO:0048385 |
regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 0.2 |
0.6 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.2 |
0.6 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.2 |
0.6 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.2 |
0.5 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.2 |
0.2 |
GO:0046719 |
regulation by virus of viral protein levels in host cell(GO:0046719) |
| 0.2 |
1.4 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.2 |
1.0 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.2 |
0.5 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.2 |
1.6 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.2 |
0.5 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 |
0.3 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.2 |
2.4 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 |
0.6 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.2 |
0.9 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.2 |
0.2 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 |
0.3 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 |
0.2 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.2 |
0.3 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.2 |
2.2 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.2 |
2.6 |
GO:0030149 |
sphingolipid catabolic process(GO:0030149) |
| 0.2 |
0.5 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 0.2 |
0.3 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.2 |
0.3 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.2 |
0.3 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.2 |
0.3 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 |
0.2 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.2 |
2.7 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.2 |
1.5 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.2 |
1.7 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.2 |
0.5 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.2 |
5.0 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.2 |
0.5 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 |
1.4 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.2 |
1.5 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.2 |
0.2 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.2 |
0.3 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.1 |
3.0 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
1.5 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.6 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.1 |
0.6 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 |
0.4 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.1 |
1.9 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 |
0.1 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.1 |
1.3 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.1 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.1 |
0.4 |
GO:0060003 |
copper ion export(GO:0060003) |
| 0.1 |
0.1 |
GO:0032714 |
negative regulation of interleukin-13 production(GO:0032696) negative regulation of interleukin-5 production(GO:0032714) |
| 0.1 |
0.4 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.1 |
0.3 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.1 |
0.3 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.1 |
0.3 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.1 |
0.6 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.1 |
1.0 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.4 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 |
0.7 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
0.3 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.1 |
2.3 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 |
0.7 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.1 |
1.0 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
1.2 |
GO:0048339 |
paraxial mesoderm development(GO:0048339) |
| 0.1 |
0.7 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
0.4 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
0.4 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.1 |
1.1 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.1 |
1.0 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
1.5 |
GO:0006337 |
nucleosome disassembly(GO:0006337) |
| 0.1 |
0.1 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.4 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.1 |
10.1 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 |
0.4 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.1 |
GO:0003071 |
renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
| 0.1 |
0.1 |
GO:0034773 |
histone H4-K20 methylation(GO:0034770) histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.8 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.4 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.1 |
1.4 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.1 |
0.8 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
1.4 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 |
1.4 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 |
0.4 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.4 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
0.1 |
GO:0045575 |
basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.1 |
0.1 |
GO:0032056 |
positive regulation of translation in response to stress(GO:0032056) |
| 0.1 |
1.5 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.4 |
GO:0002946 |
tRNA C5-cytosine methylation(GO:0002946) |
| 0.1 |
1.2 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 |
0.8 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.5 |
GO:0060857 |
establishment of glial blood-brain barrier(GO:0060857) |
| 0.1 |
0.4 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.4 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.1 |
0.1 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.1 |
0.3 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.1 |
0.1 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 |
0.1 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.1 |
0.7 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
1.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.4 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 |
3.9 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.1 |
0.5 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
0.4 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
0.8 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
0.8 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
0.6 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.1 |
0.4 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.6 |
GO:0051461 |
corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.1 |
0.9 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.4 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 |
0.6 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.1 |
0.1 |
GO:0048550 |
negative regulation of pinocytosis(GO:0048550) |
| 0.1 |
1.0 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.1 |
0.1 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 |
0.6 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.9 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 |
0.8 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.1 |
0.4 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.1 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.1 |
0.6 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
0.4 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.1 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.1 |
0.1 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.1 |
1.0 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.1 |
0.5 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
| 0.1 |
1.5 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
1.6 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
1.3 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.4 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
1.4 |
GO:0045830 |
positive regulation of isotype switching(GO:0045830) |
| 0.1 |
0.4 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.1 |
GO:0019389 |
glucuronoside metabolic process(GO:0019389) |
| 0.1 |
0.5 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.1 |
1.4 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.2 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
1.4 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
0.6 |
GO:0010998 |
regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) |
| 0.1 |
0.4 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.7 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.7 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
1.0 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.7 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
1.0 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.1 |
0.7 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.2 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 |
0.1 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.4 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
0.2 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.1 |
1.6 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.5 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
2.2 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.1 |
0.7 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
0.6 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.6 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.1 |
0.1 |
GO:1901992 |
positive regulation of mitotic cell cycle phase transition(GO:1901992) |
| 0.1 |
1.1 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.2 |
GO:0010692 |
regulation of alkaline phosphatase activity(GO:0010692) |
| 0.1 |
0.2 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.4 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.1 |
1.1 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.1 |
0.9 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.2 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
2.8 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.1 |
0.5 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.5 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.1 |
0.2 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.1 |
0.1 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.1 |
0.5 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
2.6 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
1.4 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.1 |
0.7 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 |
0.8 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
1.3 |
GO:0047497 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
0.6 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
0.3 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
0.7 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
0.5 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.1 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.1 |
0.7 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 |
0.1 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.1 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.6 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
0.4 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.1 |
0.3 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 |
0.2 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.1 |
0.7 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.1 |
5.6 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
0.2 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 |
0.4 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.1 |
0.7 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
1.1 |
GO:0036295 |
cellular response to increased oxygen levels(GO:0036295) |
| 0.1 |
0.3 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.1 |
0.3 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.1 |
0.4 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
0.3 |
GO:2001021 |
negative regulation of response to DNA damage stimulus(GO:2001021) |
| 0.1 |
1.4 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.1 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 |
0.4 |
GO:0003161 |
cardiac conduction system development(GO:0003161) |
| 0.1 |
0.3 |
GO:0070423 |
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.1 |
1.5 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.1 |
0.5 |
GO:0001916 |
positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.1 |
0.3 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 |
1.1 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.3 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
0.1 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.1 |
0.1 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.1 |
0.6 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.6 |
GO:0032400 |
melanosome localization(GO:0032400) |
| 0.1 |
0.5 |
GO:0080184 |
response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
| 0.1 |
4.1 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
0.9 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
0.4 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.6 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.1 |
0.4 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.1 |
3.4 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.1 |
0.2 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.1 |
0.3 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.6 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.1 |
1.0 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 |
0.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
1.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.2 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.9 |
GO:0098656 |
anion transmembrane transport(GO:0098656) |
| 0.1 |
0.3 |
GO:0099563 |
modification of synaptic structure(GO:0099563) |
| 0.1 |
0.3 |
GO:1900363 |
regulation of mRNA polyadenylation(GO:1900363) |
| 0.1 |
0.3 |
GO:1903672 |
positive regulation of sprouting angiogenesis(GO:1903672) |
| 0.1 |
0.3 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.1 |
0.1 |
GO:0036296 |
response to increased oxygen levels(GO:0036296) |
| 0.1 |
0.5 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 |
0.4 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 |
0.9 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.1 |
0.3 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.5 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
2.8 |
GO:0070613 |
regulation of protein processing(GO:0070613) |
| 0.1 |
0.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 |
0.1 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
0.1 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.1 |
0.6 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
0.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
1.1 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.2 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
1.3 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.3 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.1 |
1.4 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
1.4 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.1 |
0.1 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.1 |
2.2 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 |
0.3 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 |
0.2 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.1 |
0.4 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.1 |
0.6 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
0.7 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.1 |
0.9 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
0.8 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 |
0.2 |
GO:0001865 |
NK T cell differentiation(GO:0001865) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
0.6 |
GO:0045740 |
positive regulation of DNA replication(GO:0045740) |
| 0.1 |
0.2 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.4 |
GO:0051196 |
regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
| 0.1 |
0.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.1 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.1 |
0.8 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.2 |
GO:1903147 |
negative regulation of mitophagy(GO:1903147) |
| 0.1 |
0.6 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.5 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.1 |
0.5 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.1 |
0.2 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.1 |
0.5 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 |
0.5 |
GO:1903432 |
regulation of TORC1 signaling(GO:1903432) |
| 0.1 |
0.7 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.3 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.1 |
0.2 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
0.5 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
0.4 |
GO:0044783 |
G1 DNA damage checkpoint(GO:0044783) |
| 0.1 |
0.4 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
1.4 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.1 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.1 |
0.7 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
| 0.1 |
0.3 |
GO:0038089 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.1 |
0.1 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.1 |
0.5 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.9 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.2 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
2.1 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.1 |
0.1 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.1 |
1.7 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
0.6 |
GO:0098885 |
modification of postsynaptic actin cytoskeleton(GO:0098885) |
| 0.1 |
0.3 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 |
0.8 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
0.3 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.1 |
0.5 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.1 |
0.6 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.2 |
GO:0014033 |
neural crest cell differentiation(GO:0014033) |
| 0.1 |
0.1 |
GO:0060442 |
branching involved in prostate gland morphogenesis(GO:0060442) |
| 0.1 |
0.5 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.2 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.1 |
0.4 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.3 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.1 |
0.3 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 |
1.2 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
0.2 |
GO:1904645 |
response to beta-amyloid(GO:1904645) |
| 0.1 |
2.0 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.1 |
4.0 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.1 |
1.3 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.1 |
0.3 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.4 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.2 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) |
| 0.1 |
0.1 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.1 |
0.2 |
GO:0030473 |
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.1 |
0.6 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.3 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 |
0.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.2 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
0.1 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 |
0.1 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.1 |
0.3 |
GO:0031111 |
negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
| 0.1 |
0.8 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
0.9 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 |
0.6 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.1 |
1.0 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.1 |
0.2 |
GO:0010889 |
regulation of sequestering of triglyceride(GO:0010889) |
| 0.1 |
0.2 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
0.3 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 |
1.0 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.1 |
0.2 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.1 |
0.3 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 |
0.4 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
2.4 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.3 |
GO:0044803 |
multi-organism membrane organization(GO:0044803) |
| 0.1 |
0.3 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.3 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.1 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 |
0.2 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 |
0.2 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
1.0 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.2 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
1.1 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.1 |
0.6 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
| 0.1 |
4.1 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.5 |
GO:0044091 |
membrane biogenesis(GO:0044091) membrane assembly(GO:0071709) |
| 0.1 |
0.2 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.1 |
1.0 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.1 |
0.5 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 |
2.1 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.1 |
GO:0015810 |
aspartate transport(GO:0015810) |
| 0.1 |
0.2 |
GO:1901858 |
regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.1 |
0.6 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.1 |
1.0 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 |
0.6 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
1.3 |
GO:0060349 |
bone morphogenesis(GO:0060349) |
| 0.1 |
0.6 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.1 |
0.6 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.1 |
0.2 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.1 |
0.6 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.2 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 |
0.2 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.7 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
0.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.1 |
0.2 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
0.3 |
GO:0010883 |
regulation of lipid storage(GO:0010883) |
| 0.1 |
0.1 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.1 |
0.3 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
2.3 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.1 |
1.1 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.4 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
0.2 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 |
0.4 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.3 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.1 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.1 |
0.1 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.1 |
0.1 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.1 |
0.3 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.1 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.7 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.1 |
1.0 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.4 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
0.4 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.1 |
0.2 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.1 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.1 |
0.5 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
1.2 |
GO:0019432 |
triglyceride biosynthetic process(GO:0019432) |
| 0.1 |
0.1 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.1 |
0.1 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.1 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.1 |
0.5 |
GO:0050687 |
negative regulation of defense response to virus(GO:0050687) |
| 0.1 |
0.1 |
GO:0045091 |
single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.1 |
0.1 |
GO:0016553 |
base conversion or substitution editing(GO:0016553) |
| 0.1 |
0.5 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
0.1 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.1 |
0.5 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.2 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.1 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 |
0.2 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.3 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.4 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.1 |
0.2 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.3 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.1 |
0.1 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.1 |
GO:1990839 |
response to endothelin(GO:1990839) |
| 0.1 |
0.3 |
GO:0050771 |
negative regulation of axonogenesis(GO:0050771) |
| 0.1 |
0.1 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.1 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.1 |
1.8 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.1 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 0.1 |
0.2 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 |
0.5 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.1 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.1 |
0.1 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 |
0.4 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.1 |
0.2 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.1 |
0.1 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.1 |
0.1 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.1 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.3 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.1 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.1 |
0.4 |
GO:0015780 |
nucleotide-sugar transport(GO:0015780) |
| 0.1 |
0.1 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.1 |
0.2 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 |
0.4 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
0.1 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.1 |
0.4 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
0.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.3 |
GO:0031062 |
positive regulation of histone methylation(GO:0031062) |
| 0.1 |
0.1 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.7 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.5 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
0.5 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
0.1 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.1 |
0.4 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.1 |
0.4 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.6 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.4 |
GO:0072112 |
renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.1 |
0.1 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.1 |
0.2 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.1 |
0.6 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.1 |
0.1 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 0.1 |
1.5 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.1 |
1.5 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
0.2 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
1.2 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.1 |
0.3 |
GO:0030071 |
regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.1 |
0.8 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.1 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.8 |
GO:0045841 |
negative regulation of mitotic metaphase/anaphase transition(GO:0045841) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) |
| 0.1 |
0.9 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.1 |
0.5 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 |
1.1 |
GO:0042267 |
natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.1 |
0.1 |
GO:0031161 |
phosphatidylinositol catabolic process(GO:0031161) |
| 0.1 |
0.2 |
GO:2000303 |
regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.1 |
0.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
0.4 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.1 |
0.1 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
0.1 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.1 |
0.3 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.1 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.1 |
0.5 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.1 |
0.2 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.5 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.2 |
GO:0007091 |
metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
| 0.1 |
0.5 |
GO:0043536 |
positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 |
0.1 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
0.1 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.1 |
0.1 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.1 |
0.4 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.2 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 |
0.2 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 |
0.4 |
GO:0046512 |
sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.1 |
GO:0002423 |
natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
| 0.1 |
0.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.5 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 |
0.1 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.1 |
GO:0035482 |
gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.1 |
0.2 |
GO:0046645 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.1 |
0.2 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.1 |
0.2 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.2 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.0 |
0.1 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 |
0.3 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.0 |
0.4 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.0 |
GO:0031638 |
zymogen activation(GO:0031638) |
| 0.0 |
0.2 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.0 |
0.4 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.4 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.1 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) |
| 0.0 |
0.1 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.4 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.3 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
1.5 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.0 |
0.1 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.0 |
0.2 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.0 |
0.2 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.0 |
0.0 |
GO:0038202 |
TORC1 signaling(GO:0038202) |
| 0.0 |
0.3 |
GO:0031102 |
neuron projection regeneration(GO:0031102) |
| 0.0 |
0.5 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.0 |
0.4 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.0 |
GO:0034724 |
DNA replication-independent nucleosome organization(GO:0034724) |
| 0.0 |
0.1 |
GO:2000407 |
T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
| 0.0 |
0.7 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.1 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.0 |
0.4 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.0 |
0.1 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.2 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.0 |
0.1 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.0 |
2.5 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
0.2 |
GO:0038066 |
p38MAPK cascade(GO:0038066) |
| 0.0 |
0.2 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.0 |
0.8 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.3 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.0 |
0.3 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.1 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.1 |
GO:0002887 |
negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
| 0.0 |
0.1 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.0 |
0.4 |
GO:1902692 |
regulation of neuroblast proliferation(GO:1902692) |
| 0.0 |
0.6 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.3 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 |
0.6 |
GO:0043627 |
response to estrogen(GO:0043627) |
| 0.0 |
0.0 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.0 |
0.3 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.0 |
0.3 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.4 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 |
0.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.0 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.0 |
0.1 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.0 |
0.1 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.0 |
0.3 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.1 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.0 |
1.1 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.0 |
0.4 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.0 |
0.1 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.1 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.0 |
0.0 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.0 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.3 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.0 |
0.4 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
0.7 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.1 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.2 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.0 |
0.1 |
GO:0033273 |
response to vitamin(GO:0033273) |
| 0.0 |
0.4 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.2 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.0 |
0.1 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 |
0.2 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.1 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
0.7 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.0 |
0.2 |
GO:1904152 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 |
0.1 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.1 |
GO:0035963 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.0 |
0.2 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.0 |
0.3 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 |
0.3 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.0 |
0.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.0 |
0.1 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.1 |
GO:0009225 |
nucleotide-sugar metabolic process(GO:0009225) |
| 0.0 |
0.1 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.6 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.0 |
0.2 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.0 |
0.3 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.1 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.0 |
0.1 |
GO:2000109 |
macrophage apoptotic process(GO:0071888) protein sialylation(GO:1990743) regulation of macrophage apoptotic process(GO:2000109) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.0 |
0.5 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.0 |
0.0 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
0.3 |
GO:2001273 |
regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.0 |
0.9 |
GO:0032212 |
positive regulation of telomere maintenance via telomerase(GO:0032212) |
| 0.0 |
0.4 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.1 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
0.0 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.0 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.0 |
0.2 |
GO:0061718 |
NADH regeneration(GO:0006735) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 |
0.2 |
GO:0039535 |
regulation of RIG-I signaling pathway(GO:0039535) |
| 0.0 |
0.0 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.0 |
0.0 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.0 |
0.1 |
GO:0010524 |
positive regulation of calcium ion transport into cytosol(GO:0010524) |
| 0.0 |
0.0 |
GO:0042440 |
pigment metabolic process(GO:0042440) |
| 0.0 |
1.1 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.2 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.0 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.0 |
0.1 |
GO:0060677 |
ureteric bud elongation(GO:0060677) metanephric renal vesicle formation(GO:0072093) |
| 0.0 |
0.5 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.0 |
0.3 |
GO:0002455 |
humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.0 |
1.3 |
GO:0006073 |
glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
| 0.0 |
0.1 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.0 |
0.0 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.0 |
0.1 |
GO:0000423 |
macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
| 0.0 |
0.1 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.0 |
0.0 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.0 |
0.1 |
GO:1903541 |
regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
| 0.0 |
0.1 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.0 |
0.2 |
GO:0090317 |
negative regulation of intracellular protein transport(GO:0090317) |
| 0.0 |
0.2 |
GO:0044346 |
fibroblast apoptotic process(GO:0044346) negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 |
0.1 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.0 |
0.5 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.0 |
0.1 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.0 |
0.0 |
GO:0030388 |
fructose 6-phosphate metabolic process(GO:0006002) fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
0.0 |
GO:2000209 |
regulation of anoikis(GO:2000209) |
| 0.0 |
0.0 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.1 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.0 |
0.4 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.0 |
0.4 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.0 |
0.1 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.0 |
0.1 |
GO:0019883 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 |
0.1 |
GO:0009948 |
anterior/posterior axis specification(GO:0009948) |
| 0.0 |
0.2 |
GO:0097300 |
programmed necrotic cell death(GO:0097300) |
| 0.0 |
0.1 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.0 |
0.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.0 |
0.1 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.0 |
0.3 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 |
0.1 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 |
0.1 |
GO:0006720 |
isoprenoid metabolic process(GO:0006720) |
| 0.0 |
0.0 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.0 |
0.1 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 |
0.1 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.0 |
0.1 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.1 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.0 |
0.1 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.0 |
0.2 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.0 |
0.3 |
GO:0019319 |
hexose biosynthetic process(GO:0019319) |
| 0.0 |
0.1 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.0 |
0.1 |
GO:0021772 |
olfactory bulb development(GO:0021772) |
| 0.0 |
0.1 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.0 |
0.2 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.0 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.0 |
0.1 |
GO:0010935 |
macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
| 0.0 |
0.0 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.0 |
0.0 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.0 |
0.0 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.0 |
0.8 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.0 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.0 |
0.2 |
GO:1901739 |
regulation of myoblast fusion(GO:1901739) |
| 0.0 |
0.0 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.0 |
0.0 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.0 |
0.0 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) regulation of endoribonuclease activity(GO:0060699) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.0 |
0.2 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.1 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.0 |
0.1 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.0 |
0.1 |
GO:0006921 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
| 0.0 |
0.1 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
0.1 |
GO:0034035 |
sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 |
0.1 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
| 0.0 |
0.0 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.0 |
GO:0060742 |
epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.0 |
0.1 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.0 |
0.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.2 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 |
0.2 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.0 |
0.0 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.0 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.0 |
0.5 |
GO:0002262 |
myeloid cell homeostasis(GO:0002262) erythrocyte differentiation(GO:0030218) |
| 0.0 |
0.1 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.0 |
0.0 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.0 |
0.1 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.5 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.0 |
0.1 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 |
0.0 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.0 |
0.2 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.1 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.0 |
0.2 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 |
1.2 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.0 |
0.1 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.1 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.0 |
0.1 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.0 |
0.0 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 |
0.1 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.1 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.0 |
0.1 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.0 |
0.1 |
GO:2000380 |
regulation of mesoderm development(GO:2000380) |
| 0.0 |
0.2 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.1 |
GO:0090103 |
cochlea morphogenesis(GO:0090103) |
| 0.0 |
0.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.1 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.0 |
0.0 |
GO:0002327 |
immature B cell differentiation(GO:0002327) |
| 0.0 |
0.0 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.0 |
0.2 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.1 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.0 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.0 |
0.1 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
0.0 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.0 |
0.3 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 |
0.0 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
0.1 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.0 |
0.0 |
GO:0030318 |
melanocyte differentiation(GO:0030318) |
| 0.0 |
0.1 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 |
0.4 |
GO:0043039 |
tRNA aminoacylation(GO:0043039) |
| 0.0 |
0.0 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.1 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.0 |
0.1 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.1 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.0 |
0.1 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.0 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.0 |
0.0 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.0 |
0.1 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.0 |
0.0 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.0 |
0.2 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.3 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.0 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.1 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.1 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.0 |
GO:0003356 |
regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.0 |
0.0 |
GO:1902302 |
regulation of potassium ion export(GO:1902302) |
| 0.0 |
0.2 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
0.3 |
GO:0006006 |
glucose metabolic process(GO:0006006) |
| 0.0 |
0.1 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 |
0.0 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.0 |
0.0 |
GO:0044062 |
regulation of excretion(GO:0044062) |
| 0.0 |
0.3 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.0 |
0.0 |
GO:0019430 |
removal of superoxide radicals(GO:0019430) |
| 0.0 |
0.2 |
GO:1903825 |
organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
| 0.0 |
0.2 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.0 |
0.5 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.0 |
0.5 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.1 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.0 |
0.1 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.2 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.0 |
0.1 |
GO:0032435 |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.0 |
0.0 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.1 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.0 |
0.0 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.0 |
0.2 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.1 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
